Carfilzomib

Uses

Carfilzomib is used in the treatment of multiple myeloma.

How it Works

How Carfilzomib works Carfilzomib is an anti-cancer medication that functions by blocking or slowing the breakdown of proteins in cells. This leads to an increase in the number of proteins within cancer cells, ultimately resulting in their death.

Side Effects

Common side effects of Carfilzomib include fatigue, anemia (low red blood cell count), nausea, fever, diarrhea, vomiting, decreased white blood cell count (neutrophils), breathlessness, upper respiratory tract infection, headache, cough, increased creatinine level in the blood, and lymphopenia.

Expert Advice

  • Carfilzomib is administered as an intravenous (IV) infusion under the supervision of a physician.
  • Do not skip any doses; complete the treatment course as prescribed by your doctor.
  • Utilize an effective method of birth control to prevent pregnancy while receiving this medication.
  • Blood tests may be required to monitor your blood cell counts, platelet levels, liver function, and kidney function during treatment.
  • Inform your doctor immediately if you experience:
    • Unusual bruising or bleeding
    • Dark, tarry, or bloody stools
    • Sore throat
  • Notify your doctor if you observe any of the following symptoms:
    • Chest pain
    • Shortness of breath
    • Difficulty breathing
    • Dizziness
    • Swelling of the feet

Other Combinations

Frequently asked questions

Seek immediate medical attention if you experience shortness of breath, unusual bleeding, jaundice, severe headache, confusion, seizures, or vision loss.
Carfilzomib can harm an unborn baby. Women should use effective contraception during treatment and for 6 months afterward. Men should use contraception during treatment and for 3 months after.
Carfilzomib may pass into breastmilk and harm the baby. It is recommended to avoid breastfeeding during treatment and for 2 weeks after the final dose.
Carfilzomib may lower your platelet count, increasing your risk of infection. It's advisable to avoid crowds and practice good hygiene, such as frequent handwashing.
Carfilzomib, in combination with other medications, is intended for patients with relapsed or refractory multiple myeloma. Consult your doctor for personalized advice.
Yes, nausea and fatigue are common side effects. To alleviate nausea, eat smaller, more frequent meals and avoid salty, spicy, fried, or fatty foods. Rest and light exercise can help manage fatigue.
Carfilzomib is typically given in treatment cycles lasting 4 weeks, with treatment occurring 2 days a week for 3 weeks, followed by a week without treatment. Your doctor will tailor your treatment plan to your needs.
Carfilzomib is administered via intravenous (IV) infusion, delivering the medication directly into your bloodstream through a vein.
Increase fluid intake to prevent dehydration, avoid driving or operating machinery if you feel dizzy, and protect your skin from the sun with SPF 15 or higher and appropriate clothing.
;